Moneycontrol
HomeNewsBusinessCoronavirus impact | IT firms start issuing pink slips; around 1.5 lakh employees may lose their jobs
Trending Topics

Coronavirus impact | IT firms start issuing pink slips; around 1.5 lakh employees may lose their jobs

The industry employs about 45-50 lakh, of which and smaller firms account for about 10-12 lakh. The top five IT firms alone employ close to 10 lakh people

April 03, 2020 / 17:21 IST
Story continues below Advertisement

Shreeram M*, a techie working for a small IT firm in Pune, was forced to resign along with six others, in March. A fortnight later, in another ITeS-BPO firm — Fareportal — more than 300 employees were laid off.

This may just be the beginning as HR experts and industry players see around 1.5 lakh employees in India's IT industry losing their jobs over the next three-to-six months.

Story continues below Advertisement

Aditya Narayan Mishra, CEO, CIEL HR Services, a staffing firm, said majority of these layoffs will happen in small IT firms, who are dependent on a few large clients. Large and mid-tier IT firms will account for the rest.

The industry employs about 45-50 lakh, of which and smaller firms account for about 10-12 lakh. The top five IT firms alone employ close to 10 lakh people.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show